A detailed history of Bogart Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bogart Wealth, LLC holds 355 shares of LLY stock, worth $265,543. This represents 0.01% of its overall portfolio holdings.

Number of Shares
355
Previous 347 2.31%
Holding current value
$265,543
Previous $314,000 -0.0%
% of portfolio
0.01%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $6,177 - $7,680
8 Added 2.31%
355 $314,000
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $31,169 - $39,088
43 Added 14.14%
347 $314,000
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $8,883 - $11,884
15 Added 5.19%
304 $236,000
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $57,770 - $68,104
110 Added 61.45%
289 $168,000
Q3 2023

Oct 30, 2023

BUY
$434.7 - $599.3 $40,427 - $55,734
93 Added 108.14%
179 $96,000
Q2 2023

Jul 28, 2023

SELL
$350.74 - $468.98 $701 - $937
-2 Reduced 2.27%
86 $40,000
Q1 2023

Apr 21, 2023

BUY
$310.63 - $364.82 $18,016 - $21,159
58 Added 193.33%
88 $30,000
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $4,823 - $5,620
15 Added 100.0%
30 $10,000
Q3 2022

Nov 03, 2022

SELL
$296.48 - $337.87 $1,482 - $1,689
-5 Reduced 25.0%
15 $5,000
Q2 2022

Jul 22, 2022

BUY
$278.73 - $327.27 $3,623 - $4,254
13 Added 185.71%
20 $7,000
Q2 2019

Jul 11, 2019

SELL
$110.79 - $129.32 $775 - $905
-7 Reduced 50.0%
7 $0
Q1 2019

Apr 08, 2019

SELL
$111.31 - $131.02 $19,590 - $23,059
-176 Reduced 92.63%
14 $1,000
Q4 2018

Jan 15, 2019

BUY
$105.9 - $118.64 $20,121 - $22,541
190 New
190 $21,000
Q3 2018

Oct 16, 2018

SELL
$85.86 - $107.31 $16,313 - $20,388
-190 Closed
0 $0
Q2 2018

Jul 13, 2018

SELL
$75.7 - $86.88 $9,462 - $10,860
-125 Reduced 39.68%
190 $16,000
Q3 2017

Oct 12, 2017

BUY
$77.07 - $85.54 $24,277 - $26,945
315
315 $27,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bogart Wealth, LLC Portfolio

Follow Bogart Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.